0001558370-17-003547.txt : 20170504 0001558370-17-003547.hdr.sgml : 20170504 20170504165032 ACCESSION NUMBER: 0001558370-17-003547 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170504 DATE AS OF CHANGE: 20170504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMPHENOL CORP /DE/ CENTRAL INDEX KEY: 0000820313 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC CONNECTORS [3678] IRS NUMBER: 222785165 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-10879 FILM NUMBER: 17814826 BUSINESS ADDRESS: STREET 1: 358 HALL AVE CITY: WALLINGFORD STATE: CT ZIP: 06492 BUSINESS PHONE: 2032658900 10-Q 1 aph-20170331x10q.htm 10-Q aph_Current_Folio_10Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended March 31, 2017

 

OR

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 1-10879


 

Picture 1

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware

22-2785165

(State of Incorporation)

(IRS Employer Identification No.)

 

358 Hall Avenue

Wallingford, Connecticut 06492

(Address of principal executive offices) (Zip Code)

 

203-265-8900

(Registrant’s telephone number, including area code)


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

 

 

Large accelerated filer ☒

Accelerated filer ☐

 

 

Non-accelerated filer ☐

Smaller reporting company ☐

 

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

 

As of April 28, 2017, the total number of shares outstanding of the registrant’s Class A Common Stock was 305,615,575.

 

 

 

 


 

Amphenol Corporation

Index to Quarterly Report

on Form 10-Q

 

 

    

 

Page

 

 

 

 

Part I 

 

Financial Information

 

 

 

 

 

Item 1. 

 

Financial Statements (unaudited)

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2017 and December 31, 2016

2

 

 

 

 

 

 

Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2017 and 2016

3

 

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2017 and 2016

4

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flow for the Three Months Ended March 31, 2017 and 2016

5

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

6

 

 

 

 

Item 2. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

18

 

 

 

 

Item 3. 

 

Quantitative and Qualitative Disclosures About Market Risk

25

 

 

 

 

Item 4. 

 

Controls and Procedures

26

 

 

 

 

Part II 

 

Other Information

 

 

 

 

 

Item 1. 

 

Legal Proceedings

27

 

 

 

 

Item 1A. 

 

Risk Factors

27

 

 

 

 

Item 2. 

 

Unregistered Sales of Equity Securities and Use of Proceeds

27

 

 

 

 

Item 3. 

 

Defaults Upon Senior Securities

27

 

 

 

 

Item 4. 

 

Mine Safety Disclosures

27

 

 

 

 

Item 5. 

 

Other Information

27

 

 

 

 

Item 6. 

 

Exhibits

28

 

 

 

 

Signature 

 

 

30

 

 

1


 

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

 

    

2017

    

2016

 

Assets

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,242.9

 

$

1,034.6

 

Short-term investments

 

 

36.8

 

 

138.6

 

Total cash, cash equivalents and short-term investments

 

 

1,279.7

 

 

1,173.2

 

Accounts receivable, less allowance for doubtful accounts of $19.2 and $23.6, respectively

 

 

1,318.3

 

 

1,349.3

 

Inventories

 

 

962.3

 

 

928.9

 

Other current assets

 

 

162.1

 

 

139.8

 

Total current assets

 

 

3,722.4

 

 

3,591.2

 

 

 

 

 

 

 

 

 

Property, plant and equipment, less accumulated depreciation of $1,052.0 and $1,007.2, respectively

 

 

726.9

 

 

711.4

 

Goodwill

 

 

3,748.7

 

 

3,678.8

 

Intangibles, net and other long-term assets

 

 

509.4

 

 

517.3

 

 

 

 

 

 

 

 

 

 

 

$

8,707.4

 

$

8,498.7

 

 

 

 

 

 

 

 

 

Liabilities & Equity

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

682.4

 

$

678.2

 

Accrued salaries, wages and employee benefits

 

 

123.2

 

 

131.8

 

Accrued income taxes

 

 

117.7

 

 

125.1

 

Accrued dividends

 

 

48.9

 

 

49.3

 

Other accrued expenses

 

 

236.0

 

 

275.6

 

Current portion of long-term debt

 

 

375.1

 

 

375.2

 

Total current liabilities

 

 

1,583.3

 

 

1,635.2

 

 

 

 

 

 

 

 

 

Long-term debt, less current portion

 

 

2,862.1

 

 

2,635.5

 

Accrued pension and postretirement benefit obligations

 

 

288.8

 

 

288.4

 

Other long-term liabilities

 

 

222.1

 

 

216.5

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

Common stock

 

 

0.3

 

 

0.3

 

Additional paid-in capital

 

 

1,056.7

 

 

1,020.9

 

Retained earnings

 

 

3,049.5

 

 

3,122.7

 

Accumulated other comprehensive loss

 

 

(402.3)

 

 

(469.0)

 

Total shareholders’ equity attributable to Amphenol Corporation

 

 

3,704.2

 

 

3,674.9

 

 

 

 

 

 

 

 

 

Noncontrolling interests

 

 

46.9

 

 

48.2

 

Total equity

 

 

3,751.1

 

 

3,723.1

 

 

 

 

 

 

 

 

 

 

 

$

8,707.4

 

$

8,498.7

 

 

See accompanying notes to condensed consolidated financial statements.

2


 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(dollars and shares in millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2017

    

2016

 

Net sales

 

$

1,560.1

 

$

1,451.2

 

Cost of sales

 

 

1,044.2

 

 

992.0

 

Gross profit

 

 

515.9

 

 

459.2

 

Acquisition-related expenses

 

 

 —

 

 

30.3

 

Selling, general and administrative expenses

 

 

201.8

 

 

189.5

 

Operating income

 

 

314.1

 

 

239.4

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(19.3)

 

 

(18.1)

 

Other income, net

 

 

3.6

 

 

1.0

 

Income before income taxes

 

 

298.4

 

 

222.3

 

Provision for income taxes

 

 

(71.1)

 

 

(63.9)

 

Net income

 

 

227.3

 

 

158.4

 

Less: Net income attributable to noncontrolling interests

 

 

(2.4)

 

 

(1.8)

 

 

 

 

 

 

 

 

 

Net income attributable to Amphenol Corporation

 

$

224.9

 

$

156.6

 

 

 

 

 

 

 

 

 

Net income per common share — Basic

 

$

0.73

 

$

0.51

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding — Basic

 

 

306.6

 

 

307.6

 

 

 

 

 

 

 

 

 

Net income per common share — Diluted

 

$

0.71

 

$

0.50

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding — Diluted

 

 

316.4

 

 

314.2

 

 

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.16

 

$

0.14

 

 

See accompanying notes to condensed consolidated financial statements.

3


 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2017

    

2016

 

 

 

 

 

 

 

 

 

Net income

 

$

227.3

 

$

158.4

 

Total other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

62.9

 

 

46.1

 

Unrealized gain on cash flow hedges

 

 

0.1

 

 

2.3

 

Defined benefit plan adjustment, net of tax of ($2.2) and ($2.2), respectively

 

 

4.2

 

 

4.0

 

Total other comprehensive income, net of tax

 

 

67.2

 

 

52.4

 

 

 

 

 

 

 

 

 

Total comprehensive income

 

 

294.5

 

 

210.8

 

 

 

 

 

 

 

 

 

Less: Comprehensive income attributable to noncontrolling interests

 

 

(2.9)

 

 

(2.1)

 

 

 

 

 

 

 

 

 

Comprehensive income attributable to Amphenol Corporation

 

$

291.6

 

$

208.7

 

 

See accompanying notes to condensed consolidated financial statements.

4


 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

    

2017

    

2016

 

Cash from operating activities:

 

 

 

 

 

 

 

Net income

 

$

227.3

 

$

158.4

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

54.1

 

 

61.9

 

Stock-based compensation expense

 

 

12.1

 

 

11.6

 

Excess tax benefits from stock-based compensation payment arrangements

 

 

 —

 

 

(4.2)

 

Net change in components of working capital

 

 

(66.8)

 

 

(45.9)

 

Net change in other long-term assets and liabilities

 

 

11.1

 

 

12.4

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

 

237.8

 

 

194.2

 

 

 

 

 

 

 

 

 

Cash from investing activities:

 

 

 

 

 

 

 

Capital expenditures

 

 

(48.7)

 

 

(41.0)

 

Proceeds from disposals of property, plant and equipment

 

 

0.3

 

 

2.7

 

Purchases of short-term investments

 

 

(18.2)

 

 

(16.1)

 

Sales and maturities of short-term investments

 

 

122.1

 

 

13.1

 

Acquisitions, net of cash acquired

 

 

(46.6)

 

 

(1,185.8)

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

 

8.9

 

 

(1,227.1)

 

 

 

 

 

 

 

 

 

Cash from financing activities:

 

 

 

 

 

 

 

Borrowings under commercial paper program, net

 

 

225.3

 

 

50.8

 

Payment of costs related to debt financing

 

 

 —

 

 

(3.0)

 

Proceeds from exercise of stock options

 

 

23.7

 

 

14.6

 

Excess tax benefits from stock-based compensation payment arrangements

 

 

 —

 

 

4.2

 

Distributions to shareholders of noncontrolling interests

 

 

(4.2)

 

 

(4.0)

 

Purchase and retirement of treasury stock

 

 

(249.2)

 

 

(49.2)

 

Dividend payments

 

 

(49.3)

 

 

(43.2)

 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

 

(53.7)

 

 

(29.8)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

15.3

 

 

12.5

 

 

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

 

208.3

 

 

(1,050.2)

 

Cash and cash equivalents balance, beginning of period

 

 

1,034.6

 

 

1,737.2

 

 

 

 

 

 

 

 

 

Cash and cash equivalents balance, end of period

 

$

1,242.9

 

$

687.0

 

 

 

 

 

 

 

 

 

Cash paid for:

 

 

 

 

 

 

 

Interest

 

$

32.4

 

$

31.2

 

Income taxes

 

 

77.4

 

 

47.6

 

 

 

See accompanying notes to condensed consolidated financial statements.

5


 

AMPHENOL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(dollars in millions, except per share data)

 

Note 1—Basis of Presentation and Principles of Consolidation

 

The condensed consolidated balance sheets as of March 31, 2017 and December 31, 2016, and the related condensed consolidated statements of income, condensed consolidated statements of comprehensive income, and condensed consolidated statements of cash flow for the three months ended March 31, 2017 and 2016 include the accounts of Amphenol Corporation and its subsidiaries (“Amphenol”, the “Company”, “we”, “our”, or “us”).  All material intercompany balances and transactions have been eliminated in consolidation.  The condensed consolidated financial statements included herein are unaudited.  In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation in conformity with accounting principles generally accepted in the United States of America have been included.  The results of operations for the three months ended March 31, 2017 are not necessarily indicative of the results to be expected for the full year.  These condensed consolidated financial statements and the related notes should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 Annual Report”). 

 

Note 2—New Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update No. (“ASU”) 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which stipulates that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for such goods or services.  To achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract(s), (3) determine the transaction price(s), (4) allocate the transaction price(s) to the performance obligations in the contract(s), and (5) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also requires advanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers.  In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606):  Deferral of the Effective Date (“ASU 2015-14”), which deferred the effective date of FASB’s revenue standard under ASU 2014-09 by one year for all entities and permits early adoption on a limited basis.  As a result of ASU 2015-14, the guidance under ASU 2014-09 shall apply for annual reporting periods beginning after December 15, 2017, including interim reporting periods within that period.  Since 2014, the FASB has issued various related updates including, but not limited to, ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarified the implementation guidance on principal versus agent considerations, and ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarified the implementation guidance regarding performance obligations and licensing arrangements.  The Company has developed an implementation plan, involving teams across its organization to review and implement the requirements of ASU 2014-09.  We are reviewing our contracts and the related revenue streams and expect to complete our assessment in the second half of 2017.  While we continue to review and evaluate this guidance and its impact on our consolidated financial statements, we currently expect many of our businesses to continue recognizing revenue on a “point-in-time” basis, while certain businesses with more customized products may require “over time” revenue recognition under the new standard.  We are also in the process of reviewing our current systems, internal controls and processes, and evaluating any necessary changes to support the implementation of this new standard, which we expect to implement by the end of 2017.  As permitted under the standard, the Company plans to adopt ASU 2014-09 in the first quarter of 2018 using the modified retrospective approach and to recognize the cumulative effect of existing contracts in the opening balance of retained earnings on the effective date. 

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”), which amends, among other things, the existing guidance by requiring lessees to recognize lease assets (right-to-use) and liabilities (for reasonably certain lease payments) arising from operating leases on the balance sheet.  For leases with a term of twelve

6


 

months or less, ASU 2016-02 permits an entity to make an accounting policy election to recognize such leases as lease expense, generally on a straight-line basis over the lease term.  ASU 2016-02 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 using a modified retrospective approach, with early adoption permitted.  The Company is currently evaluating ASU 2016-02 and its impact on its consolidated financial statements.

 

In March 2016, the FASB issued ASU 2016-09,  Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), which simplifies certain provisions associated with the accounting for stock compensation. ASU 2016-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016, with early adoption permitted.  In the first quarter of 2017, the Company adopted ASU 2016-09, which requires any excess tax benefits and tax deficiencies to be recorded as a discrete income tax item in the statement of income in the period in which they occur.  For the three months ended March 31, 2017, this change resulted in the recognition of a tax benefit within the provision for income taxes.  Under previous accounting guidance, this cash tax benefit would have been recorded directly to equity.  Since this provision of the standard must be applied prospectively, there was no impact to prior periods.  As of January 1, 2017, the Company did not have any unrecognized excess tax benefits in which the related tax deduction did not reduce income taxes payable and therefore, there was no cumulative-effect adjustment to beginning retained earnings.  The ASU also eliminates the requirement to reclassify cash flows related to excess tax benefits from operating activities to financing activities in the statement of cash flows, but rather requires such excess tax benefits and deficiencies to be classified within operating activities, consistent with other cash flows related to income taxes.  The Company adopted this provision prospectively, and the prior period in the statements of cash flow has not been adjusted.  As permitted, the Company elected to continue its existing accounting practice of estimating forfeitures when recognizing stock-based compensation expense.  Other provisions of this standard did not and are not expected to have a material impact on our consolidated financial statements.  The impact of this guidance on our consolidated financial statements could result in significant fluctuations in our effective tax rate in the future, since tax expense will be impacted by the timing and intrinsic value of future stock-based compensation award exercises.  Refer to Note 6 and Note 15 for further discussion on the impact of this standard.

 

In March 2017, the FASB issued ASU 2017-07, Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, requiring employers to provide more details about the components of costs related to retirement benefits.  Specifically, ASU 2017-07 requires employers to report the service costs for providing pensions to employees in the same line item as other employee compensation costs, while the other pension-related costs such as interest costs, amortization of pension-related costs from prior periods, and the gains or losses on plan assets, should be reported separately and outside of the subtotal of operating income.  ASU 2017-07 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted only if adopted in the first quarter of the Company’s fiscal year.  The Company is currently evaluating ASU 2017-07 and its impact on its consolidated financial statements.  The Company will adopt this new standard in the first quarter of 2018.

 

Note 3—Inventories

 

Inventories consist of:

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

 

    

2017

    

2016

 

Raw materials and supplies

 

$

335.7

 

$

319.8

 

Work in process

 

 

330.4

 

 

313.4

 

Finished goods

 

 

296.2

 

 

295.7

 

 

 

$

962.3

 

$

928.9

 

 

Note 4—Reportable Business Segments

 

The Company has two reportable business segments: (i) Interconnect Products and Assemblies and (ii) Cable Products and Solutions. The Company organizes its reportable business segments based upon similar economic characteristics and business groupings of products, services and customers.  These reportable business segments are

7


 

determined based upon how the Company reviews its businesses, assesses operating performance and makes investing and resource allocation decisions.  The Interconnect Product and Assemblies segment primarily designs, manufactures and markets a broad range of connector and connector systems, value-add products and other products, including antennas and sensors, used in a broad range of applications in a diverse set of end markets.  The Cable Products and Solutions segment primarily designs, manufactures and markets cable, value-add products and components for use primarily in the broadband communications and information technology markets as well as certain applications in other markets.  The accounting policies of the segments are the same as those for the Company as a whole and are described in Note 1 of the notes to the consolidated financial statements in the Company’s 2016 Annual Report.  The Company evaluates the performance of business units on, among other things, profit or loss from operations before interest, headquarters’ expense allocations, stock-based compensation expense, income taxes, amortization related to certain intangible assets and nonrecurring gains and losses.

 

The segment results for the three months ended March 31, 2017 and 2016 are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interconnect Products

 

Cable Products

 

Total Reportable

 

 

 

and Assemblies

 

and Solutions

 

Business Segments

 

Three Months Ended March 31:

    

2017

    

2016

    

2017

    

2016

    

2017

    

2016

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External

 

$

1,463.5

 

$

1,367.8

 

$

96.6

 

$

83.4

 

$

1,560.1

 

$

1,451.2

 

Intersegment

 

 

2.3

 

 

1.6

 

 

10.2

 

 

6.3

 

 

12.5

 

 

7.9

 

Segment operating income

 

 

323.9

 

 

281.2

 

 

13.7

 

 

11.1

 

 

337.6

 

 

292.3

 

 

A reconciliation of segment operating income to consolidated income before income taxes for the three months ended March 31, 2017 and 2016 is summarized as follows:

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

    

2017

    

2016

 

Segment operating income

 

$

337.6

 

$

292.3

 

Interest expense

 

 

(19.3)

 

 

(18.1)

 

Other income, net

 

 

3.6

 

 

1.0

 

Stock-based compensation expense

 

 

(12.1)

 

 

(11.6)

 

Acquisition-related expenses

 

 

 —

 

 

(30.3)

 

Other operating expenses

 

 

(11.4)

 

 

(11.0)

 

Income before income taxes

 

$

298.4

 

$

222.3

 

 

 

Note 5—Changes in Equity and Noncontrolling Interests

 

Net income attributable to noncontrolling interests is classified below net income.  Earnings per share is determined after the impact of the noncontrolling interests’ share in net income of the Company.  In addition, the equity attributable to noncontrolling interests is presented as a separate caption within equity.

 

8


 

A rollforward of consolidated changes in equity for the three months ended March 31, 2017 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amphenol Corporation Shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

Additional

 

Retained

 

Comprehensive

 

Treasury

 

Noncontrolling

 

Total

 

    

(in millions)

    

Amount

    

Paid-In Capital

    

Earnings

    

Loss

    

Stock

    

Interests

    

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2016

 

308.3

 

$

0.3

 

$

1,020.9

 

$

3,122.7

 

$

(469.0)

 

$

 —

 

$

48.2

 

$

3,723.1

Net income

 

 

 

 

 

 

 

 

 

 

224.9

 

 

 

 

 

 

 

 

2.4

 

 

227.3

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

66.7

 

 

 

 

 

0.5

 

 

67.2

Distributions to shareholders of noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4.2)

 

 

(4.2)

Purchase of treasury stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(249.2)

 

 

 

 

 

(249.2)

Retirement of treasury stock

 

(3.7)

 

 

 

 

 

 

 

 

(249.2)

 

 

 

 

 

249.2

 

 

 

 

 

 —

Stock options exercised

 

0.8

 

 

 

 

 

23.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23.7

Dividends declared

 

 

 

 

 

 

 

 

 

 

(48.9)

 

 

 

 

 

 

 

 

 

 

 

(48.9)

Stock-based compensation expense

 

 

 

 

 

 

 

12.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12.1

Balance as of March 31, 2017

 

305.4

 

$

0.3

 

$

1,056.7

 

$

3,049.5

 

$

(402.3)

 

$

 —

 

$

46.9

 

$

3,751.1

 

A rollforward of consolidated changes in equity for the three months ended March 31, 2016 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amphenol Corporation Shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

 

 

Additional

 

Retained

 

Comprehensive

 

Treasury

 

Noncontrolling

 

Total

 

    

(in millions)

    

Amount

    

Paid-In Capital

    

Earnings

    

Loss

    

Stock

    

Interests

    

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2015

 

308.0

 

$

0.3

 

$

783.3

 

$

2,804.4

 

$

(349.5)

 

$

 —

 

$

39.9

 

$

3,278.4

Net income

 

 

 

 

 

 

 

 

 

 

156.6

 

 

 

 

 

 

 

 

1.8

 

 

158.4

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

52.1

 

 

 

 

 

0.3

 

 

52.4

Distributions to shareholders of noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4.0)

 

 

(4.0)

Purchase of treasury stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(49.2)

 

 

 

 

 

(49.2)

Retirement of treasury stock

 

(1.0)

 

 

 

 

 

 

 

 

(49.2)

 

 

 

 

 

49.2

 

 

 

 

 

 —

Stock options exercised, including tax benefit

 

0.7

 

 

 

 

 

19.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19.6

Dividends declared

 

 

 

 

 

 

 

 

 

 

(43.0)

 

 

 

 

 

 

 

 

 

 

 

(43.0)

Stock-based compensation expense

 

 

 

 

 

 

 

11.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11.6

Balance as of March 31, 2016

 

307.7

 

$

0.3

 

$

814.5

 

$

2,868.8

 

$

(297.4)

 

$

 —

 

$

38.0

 

$

3,424.2

 

 

Note 6—Earnings Per Share

 

Basic earnings per share (“EPS”) is computed by dividing net income attributable to Amphenol Corporation by the weighted average number of common shares outstanding.  Diluted EPS is computed by dividing net income attributable to Amphenol Corporation by the weighted average number of common shares and dilutive common shares outstanding, which relates to stock options.  A reconciliation of the basic weighted average common shares outstanding to diluted weighted average common shares outstanding for the three months ended March 31, 2017 and 2016 is as follows:

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

(dollars and shares in millions, except per share data)

    

2017

    

2016

Net income attributable to Amphenol Corporation shareholders

 

$

224.9

 

$

156.6

Basic weighted average common shares outstanding

 

 

306.6

 

 

307.6

Effect of dilutive stock options

 

 

9.8

 

 

6.6

Diluted weighted average common shares outstanding

 

 

316.4

 

 

314.2

Earnings per share attributable to Amphenol Corporation shareholders:

 

 

 

 

 

 

Basic

 

$

0.73

 

$

0.51

Diluted

 

$

0.71

 

$

0.50

 

Excluded from the computations above were anti-dilutive common shares of nil and 11.0 million for the three months ended March 31, 2017 and 2016, respectively.

 

The adoption of ASU 2016-09 in 2017, discussed in Note 2 herein, requires that excess tax benefits and tax deficiencies be excluded from the assumed proceeds available in calculating the dilutive effect of stock options under the

9


 

treasury stock method.  As required, the Company adopted this provision of the new standard prospectively, which had the effect of increasing the Company’s diluted weighted average common shares outstanding by approximately two million shares for the three months ended March 31, 2017.

 

Note 7—Commitments and Contingencies

 

The Company has been named as a defendant in several legal actions arising from normal business activities.  The Company records a loss contingency liability when a loss is considered probable and the amount can be reasonably estimated.  Although the potential liability with respect to certain of such legal actions cannot be reasonably estimated, none of such matters is expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.  The Company’s legal costs associated with defending itself are recorded to expense as incurred.

 

Certain operations of the Company are subject to environmental laws and regulations which govern the discharge of pollutants into the air and water, as well as the handling and disposal of solid and hazardous wastes.  The Company believes that its operations are currently in substantial compliance with applicable environmental laws and regulations and that the costs of continuing compliance will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

 

Note 8—Stock-Based Compensation

 

Stock-based compensation expense includes the estimated effects of forfeitures, which are adjusted over the requisite service period to the extent actual forfeitures differ or are expected to differ from such estimates.  Changes in estimated forfeitures are recognized in the period of change and impact the amount of expense to be recognized in future periods.  For the three months ended March 31, 2017 and 2016, the Company’s income before income taxes was reduced for stock-based compensation expense of $12.1 and $11.6, respectively.  In addition, for the three months ended March 31, 2017 and 2016, the Company recognized income tax benefits associated with stock-based compensation of $11.0 and $2.8, respectively.  The income tax benefit during the three months ended March 31, 2017 includes the full cash tax benefit from option exercises in the quarter in accordance with the adoption of ASU 2016-09.  Under previous accounting guidance, a portion of this benefit would have been recorded directly to equity.  The expense incurred for stock-based compensation is included in Selling, general and administrative expense in the accompanying Condensed Consolidated Statements of Income.

 

Stock Options

 

In 2009, the Company adopted the 2009 Stock Purchase and Option Plan for Key Employees of Amphenol and its Subsidiaries (the “2009 Employee Option Plan”).  The Company also continues to maintain the 2000 Stock Purchase and Option Plan for Key Employees of Amphenol and Subsidiaries (the “2000 Employee Option Plan”).  No additional stock options can be granted under the 2000 Employee Option Plan.  The 2009 Employee Option Plan authorizes the granting of additional stock options by a committee of the Company’s Board of Directors. The number of shares of the Company’s Class A Common Stock (“Common Stock”) reserved for issuance under the 2009 Employee Option Plan, as amended, is 58,000,000 shares. As of March 31, 2017, there were 12,123,770 shares of Common Stock available for the granting of additional stock options under the 2009 Employee Option Plan. Options granted under the 2000 Employee Option Plan are fully vested and are generally exercisable over a period of ten years from the date of grant. Options granted under the 2009 Employee Option Plan generally vest ratably over a period of five years from the date of grant and are generally exercisable over a period of ten years from the date of grant.

 

In 2004, the Company adopted the 2004 Stock Option Plan for Directors of Amphenol Corporation (the “2004 Directors Option Plan”).  The 2004 Directors Option Plan is administered by the Company’s Board of Directors.  As of March 31, 2017 there were 140,000 shares of Common Stock available for the granting of additional stock options under the 2004 Directors Option Plan, although no additional stock options are expected to be granted under this plan.  Options were last granted under the 2004 Directors Option Plan in May 2011.  Options granted under the 2004 Directors Option Plan are fully vested and are generally exercisable over a period of ten years from the date of grant.

10


 

Stock option activity for the three months ended March 31, 2017 was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

Average

 

Aggregate

 

 

 

 

 

Weighted

 

Remaining

 

Intrinsic

 

 

 

 

 

Average

 

Contractual

 

Value

 

 

    

Options

    

Exercise Price

    

Term (in years)

    

(in millions)

 

Options outstanding at January 1, 2017

 

32,266,391

 

$

44.14

 

7.03

 

$

744.1

 

Options granted

 

 —

 

 

 

 

 

 

 

 

 

Options exercised

 

(834,925)

 

 

 

 

 

 

 

 

 

Options forfeited

 

(45,660)

 

 

 

 

 

 

 

 

 

Options outstanding at March 31, 2017

 

31,385,806

 

$

44.54

 

6.85

 

$

835.7

 

Vested and non-vested options expected to vest at March 31, 2017

 

29,778,073

 

$

44.04

 

6.78

 

$

807.9

 

Exercisable options at March 31, 2017

 

12,788,636

 

$

33.31

 

5.20

 

$

484.2

 

 

A summary of the status of the Company’s non-vested options as of March 31, 2017 and changes during the three months then ended is as follows:

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

 

 

 

 

 

Average Fair 

 

 

 

 

 

Value at Grant

 

 

 

Options

 

Date

 

Non-vested options at January 1, 2017

 

18,725,570

 

$

7.99

 

Options granted

 

 —

 

 

 —

 

Options vested

 

(82,740)

 

 

8.17

 

Options forfeited

 

(45,660)

 

 

7.84

 

Non-vested options at March 31, 2017

 

18,597,170

 

$

7.98

 

 

During the three months ended March 31, 2017 and 2016, the following activity occurred under the Company’s option plans:

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 

 

 

 

2017

 

2016

 

Total intrinsic value of stock options exercised

 

$

34.5

 

$

20.7

 

Total fair value of stock options vested

 

 

0.7

 

 

0.4

 

 

As of March 31, 2017, the total compensation cost related to non-vested options not yet recognized was approximately $101.9 with a weighted average expected amortization period of 3.13 years.

 

The grant-date fair value of each option grant under the 2000 Employee Option Plan, the 2009 Employee Option Plan and the 2004 Directors Option Plan is estimated using the Black-Scholes option pricing model. The grant-date fair value of each restricted share grant is determined based on the closing share price of the Company’s Common Stock on the date of the grant. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Use of a valuation model for option grants requires management to make certain assumptions with respect to selected model inputs. Expected share price volatility is calculated based on the historical volatility of the Common Stock and implied volatility derived from related exchange traded options. The average expected life is based on the contractual term of the option and expected exercise and historical post-vesting termination experience. The risk-free interest rate is based on U.S. Treasury zero-coupon issuances with a remaining term equal to the expected life assumed at the date of grant. The expected annual dividend per share is based on the Company’s dividend rate.

 

11


 

Restricted Shares

 

In 2012, the Company adopted the 2012 Restricted Stock Plan for Directors of Amphenol Corporation (the “2012 Directors Restricted Stock Plan”). The 2012 Directors Restricted Stock Plan is administered by the Company’s Board of Directors.  As of March 31, 2017, the number of restricted shares available for grant under the 2012 Directors Restricted Stock Plan was 137,069.  Restricted shares granted under the 2012 Directors Restricted Stock Plan generally vest on the first anniversary of the grant date.  Grants under the 2012 Directors Restricted Stock Plan entitle the holder to receive shares of the Company’s Common Stock without payment.

 

Restricted share activity for the three months ended March 31, 2017 was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Remaining

 

 

 

Restricted

 

Fair Value at 

 

Amortization Term

 

 

  

Shares

 

Grant Date

 

(in years)

 

Restricted shares outstanding at January 1, 2017

 

16,905

 

$

57.99

 

0.38

 

Restricted shares granted

 

 —

 

 

 —

 

 

 

Restricted shares outstanding at March 31, 2017

 

16,905

 

$

57.99

 

0.13

 

 

As of March 31, 2017, the total compensation cost related to non-vested restricted shares not yet recognized was approximately $0.1 with a weighted average expected amortization period of 0.13 years.

 

Note 9—Shareholders’ Equity

 

On January 24, 2017, the Company’s Board of Directors authorized a new stock repurchase program under which the Company may purchase up to $1,000.0 of the Company’s Common Stock during the two-year period ending January 24, 2019 in accordance with the requirements of Rule 10b-18 of the Exchange Act (the “2017 Stock Repurchase Program”).  During the three months ended March 31, 2017, the Company repurchased 3.7 million shares of its common stock for $249.2.  These treasury shares have been retired by the Company and common stock and retained earnings were reduced accordingly.  The Company has not repurchased any additional shares of its common stock through April 28, 2017.  The price and timing of any future purchases under the 2017 Stock Repurchase Program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price.

 

Contingent upon declaration by the Board of Directors, the Company generally pays a quarterly dividend on shares of its Common Stock.  In October 2016, the Board of Directors approved an increase in the quarterly dividend rate from $0.14 to $0.16 per share effective with dividends declared in the fourth quarter of 2016.  For the three months ended March 31, 2017, the Company paid dividends in the amount of $49.3 and declared dividends in the amount of $48.9.  For the three months ended March 31, 2016, the Company paid dividends in the amount of $43.2, and declared dividends in the amount of $43.0.

 

Note 10—Benefit Plans and Other Postretirement Benefits

 

The Company and certain of its domestic subsidiaries have defined benefit pension plans (the “U.S. Plans”), which cover certain U.S. employees and which represent the majority of the plan assets and benefit obligations of the aggregate defined benefit plans of the Company.  The U.S. Plans’ benefits are generally based on years of service and compensation and are generally noncontributory.  Certain U.S. employees not covered by the U.S. Plans are covered by defined contribution plans.  Certain foreign subsidiaries have defined benefit plans covering their employees (the “International Plans” and, together with the U.S. Plans, the “Plans”). The following is a summary, based on the most

12


 

recent actuarial valuations of the Company’s net cost for pension benefits, of the Plans and other postretirement benefits for the three months ended March 31, 2017 and 2016: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Postretirement

 

 

Pension Benefits

 

Benefits

Three Months Ended March 31:

    

2017

    

2016

    

2017

    

2016

Service cost

 

$

2.4

 

$

2.3

 

$

 —

 

$

 —

Interest cost

 

 

5.0

 

 

5.7

 

 

0.1

 

 

0.1

Expected return on plan assets

 

 

(7.7)

 

 

(7.5)

 

 

 —

 

 

 —

Amortization of prior service cost

 

 

0.7

 

 

0.6

 

 

 —

 

 

 —

Amortization of net actuarial losses

 

 

5.7